Skip to content

Shunthi Hingvadi tablet in Menstrual cramps

To study the effect of Shunthi and Hingu Combination in the management of Udavarta Yonivyapat W.S.R.to Dysmenorrhoea. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064320
Enrollment
30
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

None listed

Sponsors

CCRAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 30 patient with clinical feature of primary dysmenorrhea will be selected. 2.Female patient between 15 to 30 age will be selected.

Exclusion criteria

Exclusion criteria: 1.Female patient with any pelvic Pathology. 2.Patient with history of any other systemic illness. 3.Patient with menstrual irregularities.

Design outcomes

Primary

MeasureTime frame
Reduction in dependency on analgesics Reduction in duration of pain Reduction in nature of painTimepoint: First Month Collection and standardization of drugs Manufacture of tablets Registration of patient in OPD of Prasuti tantra and streerog Department Second Month Follow Up Third Month Follow Up Third Month Follow Up Fourth Month Final Report

Secondary

MeasureTime frame
Reduction in ConstipationTimepoint: During each Follow Up

Countries

India

Contacts

Public ContactManojkumar Jaykumar Kulkarni

S.C.Mutha Aryangla Vaidyak Mahavidyalaya, Satara

mjk259@gmail.com9422177878

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026